CD8A and cancer: For example, Lee and Ruppin (43) constructed a 3-key variable (TMB, estimated CD8+T-cell abundance, and the fraction of samples with high PD-1gene expression) model to predict anti–PD-1/PD-L1 response across different cancer types.